Callan Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.23M | Buy |
4,600
+211
| +5% | +$102K | 0.16% | 67 |
|
|
2024
Q4 | $1.77M | Sell |
4,389
-132
| -3% | -$53.2K | 0.13% | 77 |
|
|
2024
Q3 | $2.1M | Buy |
4,521
+81
| +2% | +$37.7K | 0.15% | 73 |
|
|
2024
Q2 | $2.08M | Buy |
4,440
+108
| +2% | +$50.6K | 0.17% | 65 |
|
|
2024
Q1 | $1.81M | Buy |
4,332
+141
| +3% | +$58.9K | 0.16% | 67 |
|
|
2023
Q4 | $1.71M | Buy |
4,191
+3,091
| +281% | +$1.26M | 0.16% | 68 |
|
|
2023
Q3 | $383K | Buy |
1,100
+55
| +5% | +$19.1K | 0.04% | 137 |
|
|
2023
Q2 | $368K | Hold |
1,045
| – | – | 0.04% | 128 |
|
|
2023
Q1 | $329K | Hold |
1,045
| – | – | 0.04% | 140 |
|
|
2022
Q4 | $302K | Buy |
+1,045
| New | +$302K | 0.04% | 143 |
|